Mitochondrial (mt) diseases are devastating neurodegenerative pathologies due to mutations in nuclear or mt genes. Among mtDNA pathogenic mutations, more than one half has been identified in transfer RNA (tRNA) genes. These are responsible for a wide range of pathologies including myopathies, encephalopathies, cardiomyopathies and deafness for which no effective treatment is available at present. Therefore, new strategies to suppress their damaging effects are required to envisage therapeutic approaches for these diseases. Here we report data for carbon nanotubes (CNTs) derivatives showing that the conjugates bearing a specific peptide sequence are able to target the mitochondria in yeast and human monocyte cells while the control derivative without the peptide diffuses into cytoplasm. Moreover the compounds do not affect cellular viability and cytotoxicity both in vitro and in vivo. Toxicity of the constructs is also assessed on the simple pluricellular model Caenorhabditis elegans.
Introduction
Currently different strategies such as those aimed at mt tRNA delivery or mt ATP increased production have been proposed for treatment of respiratory chain deficiencies especially due to mutations in mt tRNA genes. Nevertheless, at present, no treatments or therapies have been successfully utilized.
Based on the evidences provided so far, sequences derived from the carboxy-terminal domain of human mt LeuRS (LeuRS-Cterm) are an attractive new candidate for future therapeutic applications in mt tRNA related diseases and open a number of potential additional therapeutic approaches.
Studies on the yeast model revealed that overexpression of the nuclear genes coding for the mt aaRS 1,2,3,4,5 rescued the growth-defective phenotype of strains carrying human equivalent point mutations in the cognate mt tRNAs 1 .
The results obtained in the yeast model have been paralleled in human cell lines, 6,7,8, 9 and we demonstrated that human mt LeuRS-Cterm is the region necessary and sufficient to suppress the mt defects of mutants in both cognate and non-cognate mt tRNAs (namely tRNA Leu(UUR) , tRNA Ile , tRNA Val , all of which are aminoacylated by Class Ia aaRSs) with higher rescuing activity than the whole mt LeuRS 10, 11 .
Moreover we have previously demonstrated that the yeast mt LeuRS-Cterm was endowed with mt targeting activity 5 . We have also identified the minimal sequences of the mt LeuRS-Cterm responsible for suppression. The short isolated peptides of 15 and 16 amino acids (named β30_31 and β32_33) were endowed with the same suppressing activity of the full Cterm when overexpressed in a broad range of different yeast mt tRNA mutants 5, 12 . In vitro experiments demonstrated that mt LeuRS-Cterm peptide was able to directly and specifically interact either with human cognate mt tRNA Leu(UUR) either with non-cognate mt tRNA Ile even if with 4-fold lower affinity 11 . Moreover we have shown that the β30_31 peptide specifically interacts with cognate and non-cognate mt tRNAs 5, 13 . The demonstration that the catalytic function of mt LeuRS is not 5 required for rescuing activity and that the interaction occurring between the mt LeuRS-Cterm domain and the cognate or non-cognate tRNA in in vitro shift binding experiment 5 strongly point to a 'chaperone-like' molecular effect. We hypothesized that the interaction of the overexpressed sequences with the mutated mt tRNA stabilizes the native-like tRNA structure which would better establish interactions with other macromolecular partners required for mt protein synthesis, and/or arises less susceptible to degradation events.
In recent years the mt targeting has been proposed as a new therapeutic approach for mt dysfunction-related diseases. At present highly active compounds have been identified; however, the enormous challenge that should be overcome is mainly due to the difficult road that these molecules have to take for mt entrance from the cellular surface. This way is further complicated because the extremely complex nature of the mitochondria themselves.
Over the last decade, nanotechnology has been extensively introduced into biomedical applications, including biological detection, drug delivery, diagnostic imaging, and tissue engineering 14 .
Nanotechnology based delivery vehicles provide numerous advantages to increase the therapeutic activities of small molecules 15 .
CNTs are a very promising nanomaterial and there are many studies on their possible application as scaffold for tissue regeneration, biosensors and drug vectors 16, 17 . The characteristics that render them so interesting are ranging from their peculiar one dimension structure to their electronic properties. From the structural point of view, CNTs can present one or many concentric walls (single and multi-walled CNTs, SWCNTs and MWCNTs, respectively), and they can vary in diameter, chirality and length. Their tendency to aggregate can be overcome by chemical functionalization, which can be non covalent or covalent. These two approaches result in different pros and cons, in fact while in the first case the electronic characteristics of CNTs are preserved without the disruption of the aromatic system, the second approach changes the hybridization of the 6 carbon atoms from sp 2 to sp 3 . However, the covalent derivatization leads to more stable systems in which the introduced functionalizations cannot be easily detached from the surface. Another difference that plays an important role in the biological application of CNTs is due to the different internalization mechanism depending on the functionalization pattern. CNTs in fact are able to enter the cells both via an energy-dependent, endosomally mediated internalization mechanism 18 and via direct translocation through the plasma membrane into the cytoplasm 19,20 . Between the two possible pathways of internalization, the nature of the functionalization of nanotubes seems to be of great importance. Indeed, the presence of biomacromolecules such as proteins, antibodies, DNA or phospholipidic structures supramolecularly linked on the nanotube surface has been associated with energy-dependent endocytotic uptake 18 . It means that, the direct conjugation of short peptides on the CNTs surface could allow the direct internalization of the system, escaping the endosomal pathway and surviving the lisosomal destiny. The potential benefits of integrating nanomaterials based on carbon nanotubes have been recently engineered to target mitochondria 21, 22 .
Here we test the mt delivery activity of MWCNTs conjugated with the short peptide of 16 amino acids (β32_33) derived from the Cterm of human mt LeuRS. Fluorescence microscopy shows mt localization in yeast and human monocyte cells for these constructs, while the control without the peptide β32_33 is diffused in the cytoplasm; when the peptide is conjugated the mt targeting activity is improved at least in monocyte cells. Moreover, Caenorhabditis elegans lifespan and fertility are not affected by CNTs treatments.
Experimental

Synthesis of CNTs
The peptides with and without FITC have been purchased from CRIBI (Centro di BiotecnologieUniversity of Padova). In the suppressive sequence, a cysteine residue at the N-terminus has been fluorescence spectrophotometer using quartz cuvettes with a path length of 1 cm. Kaiser Test was applied to functionalized MWCNTs through the experimental procedure reported elsewhere 23 . The UV/Vis-NIR spectroscopic measurements implied in this analysis were carried out on a Varian
Cary 5000 spectrophotometer using polystyrene cuvettes with a path length of 1 cm. Syntheses of amino acids 1 24 and 2 25 were performed as already reported in literature. The solid cake was re-dispersed in DMF by aid of bath sonication, and the filtration process was repeated enough times to eventually obtain a colourless filtrate. Then, the same filtration was Test after selective deprotection of the Boc protecting group). For the experiments the f-MWCNT 5, f-MWCNT 8 and f-MWCNT 10 preparations were resuspended in phosphate buffered saline PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4) to have 1 mg/mL of concentration. Before using they were bath-sonicated for 2 h.
f-MWCNT
Yeast experiments
Saccharomyces cerevisiae wild type (WT) strain used in these studies was the W303-1A (MAT a, Processing System and objective lens 63x Oil).
Human monocyte experiments
Human peripheral blood mononuclear cell cultures were prepared as follow: fresh EDTA-treated 
Caenorhabditis elegans assays
The wild type Caenorhabditis elegans N2 and Escherichia coli OP50 strains (C. elegans food source) were used in this work according to standard protocol 27 .
14 Approximately 20 young adults hermaphrodites grown at 16°C, from a synchronized culture, were picked onto 3.5-cm-diameter NGM (Nematode growth media) plate contained OP50 E. coli. An aliquot (100 µL) of 100 µg/mL nanotubes suspension, were added or not to the plates and the nematodes were incubated for several days at 16°C. Every day, animals were transferred to new plates and 100 µL of nanotubes suspensions or PBS as a control were distributed on the NGM plates, before nematodes seeding. Worm death was scored by the absence of touch-provoked movement. We observed 60 worms at each time point and repeated the experiments three times.
After 24 h nanotubes-treatment, 1-day adult worms were allowed to lay eggs at 16°C on NGM supplemented with E. coli OP50. Briefly, worms were transferred onto a new bacteria plate every day, and the number of newly hatched larvae was counted with a Zeiss Axiovert 25 microscope (Thornwood, NY). This was repeated for 4 days until the mother worms stopped laying eggs. Each day the progeny production was recorded and was compared with the untreated controls.
Statistical analysis
Experiments were performed at least in triplicate. Data are presented as mean ± SD, and Student'stest or one-way ANOVA analysis coupled with a Bonferroni post test (GraphPad Prism 4.0 software) was used to determine the statistical significance between experimental groups. Statistical significance was defined as * p < 0.05, * * p< 0.01, and * * * p< 0.001.
Results
The aim of the present study is to evaluate the cellular internalization of multi-walled carbon We treated first WT yeast cells, with three different fluorescent-labelled MWCNTs (Fig. 1) . The preparation of the CNT derivatives started with a first cycloaddition in presence of phthalimide protected amino acid and paraformaldehyde (Fig. 2) , followed by a second one using a Bocprotected amino acid in order to have the orthogonal system f-MWCNT 3 to work with. This derivative has been fully deprotected and conjugated with FITC, to obtain the reference compound f-MWCNT 5. In order to introduce the selected peptide, the phthalimide was removed to expose amine groups, exploited to link a maleimide residue (f-MWCNT 7). Derivative f-MWCNT 7 has been conjugated with the fluorescently labelled peptide (f-MWCNT 8) and with the non-labelled sequence. For the latter, FICT has been introduced in a following step (f-MWCNT 10).
Yeast Experiments
We first studied cellular viability and toxicity; WT cells were inoculated in complete medium and grown overnight at 28°C. Diluted culture (10 6 cell/mL) was exposed to increasing amount of (Fig. 3B-C) . No considerable difference of the signal is observed using different amounts of the peptide conjugates.
Moreover, treatments with DAPI or MitoTracker Red and sequent co-localization of fluorescence show that f-MWCNT 8 and f-MWCNT 10 reached the mitochondria (Fig. 4A-B) , with best colocalization observed for the latter. This behaviour may be related with the different molecular structure of the constructs; in particular the f-MWCNT 8 has FITC and peptide directly linked whereas in the f-MWCNT 10 they are separated. The presence of the FITC on the peptide could in principle partially hinder the mitochondrial sequence, rendering the latter less prone to the recognition process. It is interesting to underline that, comparing the three pictures, the presence of 
Monocyte cytotoxicity assessment in vitro
Human monocytes and macrophages are cells known to be involved in both the innate and adaptive immune responses, the role of which is equally fundamental in the initiation, maintenance and resolution of inflammatory processes. For this purpose, we tested circulating monocytes, because they represent the first line of defense in the immune response to foreign materials, including nanostructures in general. Thus they are of particular relevance in the investigation of the cell ability to internalize foreign body materials and of the toxic/proinflammatory potential of the materials.
The in vitro viability of PBMCs (Peripheral blood mononuclear cells) exposed to MWCNTs conjugates was tested by different approaches (Fig. 5) : checking the release of the cytosolic enzyme lactate dehydrogenase (LDH) by using a LDH diagnostic kit; and the possible effect on the cell mt 17 function by the MTT test. The measurement of LDH in the cell culture supernatants after 24 h and 48 h indicates no significant increase of LDH levels when the cells were exposed to f-MWCNT 5, f-MWCNT 8 and f -MWCNT 10, indicating a negligible cytotoxicity of these substrates on PBMCs (Fig. 5A) . The MTT test further confirmed PBMC viability, showing that the conjugates do not affect cell mt function (Fig. 5B) .
Monocyte microscopy
We further evaluated the internalization of fluorescently-labelled MWCNTs and localization by fluorescence microscopy after 24 h, 48 h and 120 h of treatment with 100 μg/mL of constructs (Fig.   6 ). Since the time of treatment did not change the fluorescence intensity, we show a choice of pictures as example (Fig. 6) . We observed that the PBMCs treated with the f-MWCNT 5 (the vector control without the peptide sequence) for 24 h and 48 h have a diffused fluorescence ( Fig.   6A) , whereas in the same cells treated with f-MWCNT 8 or f-MWCNT 10 a separated fluorescent dots appear (Fig. 6B-C) . After 24 h of treatment the MWCNTs were internalized; after 48 h and 120 h of incubation it was possible to find higher number of fluorescent nanotubes into the cells.
Treatment with MitoTracker Red and sequent co-localization of fluorescence shows that the best result is observed when the cells were incubated for longer times with MWCNTs (48 h and 120 h).
As previously observed for the yeast cells, the best co-localization between the mt signal and the MWCNTs is obtained when the peptide sequence is present, especially in the case of f-MWCNT 10 construct (Fig. 6C ). These results demonstrate that mt targeting activity of the β32_33 peptide is optimized when this peptide is not bound to the FITC.
Longevity and genotoxicity of Caenorhabditis elegans exposed to CNTs
In order to evaluate the in vivo toxicity of these nanostructures, the nematode Caenorhabditis elegans, a well-established model system in nanotoxicology, was used 28 . We first analyzed the effects of nanotubes on the worm longevity. A population of 1-day adult hermaphrodites was transferred on NGM E. coli OP50 plates on which 100 μL of nanotube suspensions (100 µg/mL) was distributed, before nematodes seeding. Afterward, the viability was examined with respect to untreated animals (Fig. 7A) . The life-span showed no significant differences between the worms treated with the two peptide-conjugated nanotubes (f-MWCNT 8 and f-MWCNT 10) and the control, meanwhile the nanotube f-MWCNT 5 induced a slight decrease in the survival.
To deeper investigate nanostructures bioassessment, we also analyzed C. elegans reproductive potential as an indicator of genotoxicity. Hence, a brood size assay for animals exposed every day to the nanotubes was performed. The progeny production of worms exposed to FITC-conjugated nanotubes with or without the peptide was almost identical to the untreated controls (Fig. 7B) .
Discussion
Overexpression of the oligonucleotide sequences coding for the peptides β30_31 In view of potential therapeutic applications, a suitable carrier is necessary since peptides are unlikely to pass cell and mt membranes and to possess satisfactory bioavailability properties.
Nanotechnology based delivery vehicles provide numerous advantages to increase the therapeutic activities of small molecules, usually conferring them a better pharmacokinetics. Moreover, nanovehicles can be modified to target specific cells or organelles in order to carry the drug to the effective site of action. It is accepted that to deliver molecules inside the mt matrix and to have spatio-temporal control over drug release in different mt compartments, nanoparticles need to be engineered with precise size, lipophilic surface, appropriate charge, and specific targeting moieties 19 on the surface. Moreover requirements of biocompatibily and biodegradability of the materials are necessary to envision potential in vivo uses of those platforms.
Currently described methods for mt gene therapy are allotropic genes, importable tRNAs, antigenome agents, liposomes and ions, RNA transporters 29 .
The applicability of these interesting approaches in vivo remains to be determined and there are problems related to the uptake and localization of these artificial compounds, and evidence for functional delivery of DNA is lacking.
It should be noted that up to now none method has the demonstrated capability to cure mt diseases and successful gene replacement within mitochondria through homologous recombination has not
been obtained yet. Therefore, non-viral vectors technique and new selective treatments to deliver molecules directly to mitochondria should be developed.
Several studies investigated the possibility of using mitochondria-targeted micelles, dendrimers and other materials 30, 31 . For example liposomes emerged as promising mitochondria delivery system in fact they were found to co-localize with MitoTracker Red in mitochondria, however size and polydispersity are the drawbacks of this technology 32 .
Among the numerous types of nanocarriers proposed since now, carbon nanotubes are emerging as possible delivery system.
Recently it has been reported that MWCNTs conjugated to a mitochondria targeting peptide Our results indicate that the peptide sequence originally identified to have intrinsic mt targeting activity when overexpressed by plasmid in yeast and cybrid cells 5,12,13 has similar property when conjugated to MWCNTs. In fact, f-MWCNT 10 bearing peptide CKKSFLSPRTALINFLVK ( Fig.   1) , significantly improves the mt co-localization of FITC and mt fluorescence signals with respect to f-MWCNT 8 and, especially, to f-MWCNT 5 ( Fig. 4 and 6 are conserved in C. elegans. Our data indicated that the all the analyzed constructs did not affect the life-span, the brood size and the reproductive potential of the nematodes although the FITCconjugate (f-MWCNT 5) slightly decreased the survival of the animals (Fig. 7) . It has been reported that MWCNTs exposure can produced damage in C. elegans on the functions of both primary and secondary targeted organs and that MWCNTs could be translocated into the secondary targeted organs such as reproductive organs 35, 36 . However, it should be taken into account the different size, shape, and surface functionality of the several MWCNTs tested, reflecting different degrees of toxicity.
Overall, f-MWCNT 10 can be considered a good nanoplatform for delivering of bioactive molecules and treating mt tRNAs deficiencies, although for its further development as drug delivery agent will be necessary to investigate the efficacy of the construct in cell lines bearing mt dysfunctions. 
